Use of somatostatin analogs in control of hypoglycemia
US9314508B2 · kind B2 · utility
0Cited by
2References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 7, 2009 |
| Grant date | Apr 19, 2016 |
| Priority date | — |
| Expiry date | Jul 4, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of a Somatostatin (SRIF) analog which has a high binding affinity to human SSTR1,2,3,5, or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical composition for the control of hypoglycemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.